These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 20847101)

  • 1. OptCDR: a general computational method for the design of antibody complementarity determining regions for targeted epitope binding.
    Pantazes RJ; Maranas CD
    Protein Eng Des Sel; 2010 Nov; 23(11):849-58. PubMed ID: 20847101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phage-displayed antibody libraries of synthetic heavy chain complementarity determining regions.
    Sidhu SS; Li B; Chen Y; Fellouse FA; Eigenbrot C; Fuh G
    J Mol Biol; 2004 Apr; 338(2):299-310. PubMed ID: 15066433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies.
    Rothe C; Urlinger S; Löhning C; Prassler J; Stark Y; Jäger U; Hubner B; Bardroff M; Pradel I; Boss M; Bittlingmaier R; Bataa T; Frisch C; Brocks B; Honegger A; Urban M
    J Mol Biol; 2008 Feb; 376(4):1182-200. PubMed ID: 18191144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of CDR-derived peptides is mechanistically different from that of high-affinity parental antibodies.
    Timmerman P; Shochat SG; Desmet J; Barderas R; Casal JI; Meloen RH; Altschuh D
    J Mol Recognit; 2010; 23(6):559-68. PubMed ID: 21038356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic classification of CDR-L3 in antibodies: implications of the light chain subtypes and the VL-VH interface.
    Kuroda D; Shirai H; Kobori M; Nakamura H
    Proteins; 2009 Apr; 75(1):139-46. PubMed ID: 18798566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A germline knowledge based computational approach for determining antibody complementarity determining regions.
    Zhao S; Lu J
    Mol Immunol; 2010 Jan; 47(4):694-700. PubMed ID: 19939452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting antibody complementarity determining region structures without classification.
    Choi Y; Deane CM
    Mol Biosyst; 2011 Dec; 7(12):3327-34. PubMed ID: 22011953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis of affinity maturation of the TEPC15/Vkappa45.1 anti-2-phenyl-5-oxazolone antibodies.
    Scotti C; Gherardi E
    J Mol Biol; 2006 Jun; 359(5):1161-9. PubMed ID: 16682055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cluster and information entropy patterns in immunoglobulin complementarity determining regions.
    Culler S; Hsiao TR; Glassy M; Chau PC
    Biosystems; 2004 Nov; 77(1-3):195-212. PubMed ID: 15527957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
    Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB
    J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forces and energetics of hapten-antibody dissociation: a biased molecular dynamics simulation study.
    Paci E; Caflisch A; Plückthun A; Karplus M
    J Mol Biol; 2001 Nov; 314(3):589-605. PubMed ID: 11846569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-throughput generation of synthetic antibodies from highly functional minimalist phage-displayed libraries.
    Fellouse FA; Esaki K; Birtalan S; Raptis D; Cancasci VJ; Koide A; Jhurani P; Vasser M; Wiesmann C; Kossiakoff AA; Koide S; Sidhu SS
    J Mol Biol; 2007 Nov; 373(4):924-40. PubMed ID: 17825836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial repertoire of anti-(4-hydroxy-3-nitrophenylacetyl) antibodies as potential donors for effective affinity maturation.
    Furukawa K; Manabe A; Furukawa A; Kuba H; Okajima T; Azuma T
    Mol Immunol; 2006 Apr; 43(11):1751-60. PubMed ID: 16406527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-reactive binding of cyclic peptides to an anti-TGFalpha antibody Fab fragment: an X-ray structural and thermodynamic analysis.
    Hahn M; Winkler D; Welfle K; Misselwitz R; Welfle H; Wessner H; Zahn G; Scholz C; Seifert M; Harkins R; Schneider-Mergener J; Höhne W
    J Mol Biol; 2001 Nov; 314(2):293-309. PubMed ID: 11718562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Function blocking antibodies to neuropilin-1 generated from a designed human synthetic antibody phage library.
    Liang WC; Dennis MS; Stawicki S; Chanthery Y; Pan Q; Chen Y; Eigenbrot C; Yin J; Koch AW; Wu X; Ferrara N; Bagri A; Tessier-Lavigne M; Watts RJ; Wu Y
    J Mol Biol; 2007 Feb; 366(3):815-29. PubMed ID: 17196977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational characterization of B-cell epitopes.
    Rubinstein ND; Mayrose I; Halperin D; Yekutieli D; Gershoni JM; Pupko T
    Mol Immunol; 2008 Jul; 45(12):3477-89. PubMed ID: 18023478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection, characterization and x-ray structure of anti-ampicillin single-chain Fv fragments from phage-displayed murine antibody libraries.
    Burmester J; Spinelli S; Pugliese L; Krebber A; Honegger A; Jung S; Schimmele B; Cambillau C; Plückthun A
    J Mol Biol; 2001 Jun; 309(3):671-85. PubMed ID: 11397088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A universal combinatorial design of antibody framework to graft distinct CDR sequences: a bioinformatics approach.
    Haidar JN; Yuan QA; Zeng L; Snavely M; Luna X; Zhang H; Zhu W; Ludwig DL; Zhu Z
    Proteins; 2012 Mar; 80(3):896-912. PubMed ID: 22180101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shark IgNAR antibody mimotopes target a murine immunoglobulin through extended CDR3 loop structures.
    Simmons DP; Streltsov VA; Dolezal O; Hudson PJ; Coley AM; Foley M; Proll DF; Nuttall SD
    Proteins; 2008 Apr; 71(1):119-30. PubMed ID: 17932913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving antibody binding affinity and specificity for therapeutic development.
    Bostrom J; Lee CV; Haber L; Fuh G
    Methods Mol Biol; 2009; 525():353-76, xiii. PubMed ID: 19252851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.